Stephanie Ascher
Head of Investor Relations
CytomX Therapeutics, Inc. (CTMX)Equibles does not estimate personal net worth.
Get an email with a short summary when CytomX Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get CTMX alertsAbout Stephanie Ascher
Stephanie Ascher is recorded as Head of Investor Relations at CytomX Therapeutics, Inc. (CTMX). CytomX Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CytomX Therapeutics, Inc. includes Sean McCarthy (CEO and Board Member), Chris Ogden (CFO and Chief Accounting Officer), Lloyd A. Rowland (General Counsel) and 7 others.
Affiliation history
-
Current
Company network
Leadership on record at CytomX Therapeutics, Inc.
- Sean McCarthy CEO, Board Member
- Chris Ogden CFO, Chief Accounting Officer
- Lloyd A. Rowland General Counsel
- Alan Ashworth Board Member
- Alan Ashworth, Ph.D., FRS Board Member
- Charles Fuchs, M.D., M.P.H. Board Member
- Elaine V. Jones Board Member
- Elaine V. Jones Ph.D Board Member
- Elaine V. Jones Ph.D. Board Member
- Halley Gilbert Board Member
Recent activity
No call appearances or filed executive changes recorded yet.